By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Medical Answers > How is Sublocade administered?

How is Sublocade administered?

Answers by TheMediTary.Com - Last updated: 14-Jul-2023

Sublocade (buprenorphine) is given by a health care provider once a month by subcutaneous (under the skin) injection in the abdominal (stomach) region (with at least 26 days between doses). Your doctor will order this medicine for you, and you will receive it a clinic or doctor's office.

Sublocade is only available through a restricted program called the Sublocade REMS Program due to risk of harm or death due to intravenous (IV) self-administration. You will receive more information about this program from your doctor.

Sublocade (buprenorphine), from Indivior, is an extended-release, once-monthly injection for opioid use disorder (OUD). It is used in adult patients already on a stable dose of transmucosal (absorbed via mucus membrane) buprenorphine for a minimum of 7 days. Sublocade may reduce the burden of taking daily medication for patients in recovery.

Sublocade changes to a solid "depot" form after the injection. Your medicine will slowly release from this depot. You may feel a small bump under your skin after you receive the injection. Do not try to remove the depot, rub or massage the area where injected. Do not let belts or waistbands rub against the injection site.

What is the dose of Sublocade?

Sublocade is available in a prefilled syringe as a 100 mg per 0.5 mL or 300 mg per 1.5 mL strength of buprenorphine.

The recommended dose of Sublocade following stabilization with transmucosal buprenorphine is 300 mg monthly for the first two months followed by a maintenance dose of 100 mg monthly.

Your doctor may choose to increase the maintenance dose to 300 mg monthly if you tolerate the 100 mg dose, but do not have an acceptable clinical response, as shown by self-reported use of opioids or positive opioid urine drug screens.

If you miss a dose, contact your doctor as soon as possible to reschedule your appointment.

For more information see our slideshow Opioid Use Disorder: These Treatments Are Available, Now

This is not all the information you need to know about Sublocade (buprenorphine) for safe and effective use. Review the full Sublocade information here, and discuss this information and any questions you have with your doctor or other health care provider.

Share this Article

Featured questions

  • How and where is the Sublocade injection given?
  • Is Sublocade an addictive drug?
  • How long does Sublocade take to work?
  • Is Sublocade a controlled substance?
  • Is Sublocade covered by Medicaid?
  • How does Sublocade work?
  • Who makes Sublocade in the U.S?
  • Sublocade vs Suboxone - What's the difference between them?
  • How long does Sublocade last?
  • Does Sublocade have naloxone in it?
  • Does Sublocade need to be refrigerated?
  • Is Probuphine better than Sublocade?
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch (Hydrocortisone topical)
Centrum Adult (Multivitamins and minerals)
Crovalimab
Cyltezo Prefilled Syringe (Adalimumab)
Zepbound Pen (Tirzepatide)
Mylanta One (Calcium carbonate, magnesium hydroxide, and simethicone)
Uretron Ds (Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate)
Medihoney Wound And Burn Dressing (Topical emollients)
Lidotrode
Libervant (Diazepam (buccal))
Moderna Covid-19 (Covid-19 (6m-11y) vaccine, moderna (2024-2025))
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by